138 related articles for article (PubMed ID: 37329812)
1. Novel antimicrobial peptide DvAMP serves as a promising antifungal agent against Cryptococcus neoformans.
Yang L; Tian Z; Zhao W; Zhang J; Tian C; Zhou L; Jiao Z; Peng J; Guo G
Bioorg Chem; 2023 Sep; 138():106679. PubMed ID: 37329812
[TBL] [Abstract][Full Text] [Related]
2. The Antimicrobial Peptide MK58911-NH
Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
[TBL] [Abstract][Full Text] [Related]
3. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
4. A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans.
Zhang Y; Zhou L; Liu Y; Zhao X; Lian X; Zhang J; Zhao D; Wang Y; Zhong J; Wang J; Wang H; Wang L; Fu YV
Microbiol Spectr; 2022 Feb; 10(1):e0082621. PubMed ID: 35019693
[TBL] [Abstract][Full Text] [Related]
5. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo synergistic effects of hydroxychloroquine and itraconazole on Cryptococcus neoformans.
Wang X; Long X; Jia S; Zhu J; Zhou Z; Ahmed S; Jiang Y; Jiang Y
Folia Microbiol (Praha); 2023 Aug; 68(4):595-605. PubMed ID: 36753031
[TBL] [Abstract][Full Text] [Related]
7. Sensitive bioluminescence imaging of cryptococcosis in
Vanhoffelen E; Vermoesen L; Michiels L; Lagrou K; Reséndiz-Sharpe A; Vande Velde G
Virulence; 2024 Dec; 15(1):2327883. PubMed ID: 38465639
[No Abstract] [Full Text] [Related]
8. Cryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonella.
Trevijano-Contador N; Herrero-Fernández I; García-Barbazán I; Scorzoni L; Rueda C; Rossi SA; García-Rodas R; Zaragoza O
Virulence; 2015; 6(1):66-74. PubMed ID: 25531532
[TBL] [Abstract][Full Text] [Related]
9. Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the
Tancer RJ; Wang Y; Pawar S; Xue C; Wiedman GR
Microbiol Spectr; 2022 Apr; 10(2):e0043922. PubMed ID: 35377230
[TBL] [Abstract][Full Text] [Related]
10. Thiazole derivatives act on virulence factors of Cryptococcus spp.
de Sá NP; de Barros PP; Junqueira JC; Vaz JA; de Oliveira RB; Rosa CA; Santos DA; Johann S
Med Mycol; 2019 Jan; 57(1):84-91. PubMed ID: 29471408
[TBL] [Abstract][Full Text] [Related]
11. Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors.
De Jesus DFF; De Freitas ALD; De Oliveira IM; De Almeida LC; Bastos RW; Spadari CC; Melo ASA; Santos DA; Costa-Lotufo LV; Reis FCG; Rodrigues ML; Stefani HA; Ishida K
Antimicrob Agents Chemother; 2023 Mar; 67(3):e0075922. PubMed ID: 36815840
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K
Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690
[TBL] [Abstract][Full Text] [Related]
13. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Spadari CC; Vila T; Rozental S; Ishida K
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051
[No Abstract] [Full Text] [Related]
15. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
mBio; 2016 May; 7(3):. PubMed ID: 27165800
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of pyrvinium pamoate and posaconazole against
Li Y; Li S; Chen M; Xiao J; Fang H
Front Cell Infect Microbiol; 2022; 12():1074903. PubMed ID: 36569209
[TBL] [Abstract][Full Text] [Related]
17. Brilacidin, a novel antifungal agent against
Diehl C; Pinzan CF; de Castro PA; Delbaje E; García Carnero LC; Sánchez-León E; Bhalla K; Kronstad JW; Kim D-g; Doering TL; Alkhazraji S; Mishra NN; Ibrahim AS; Yoshimura M; Vega Isuhuaylas LA; Pham LTK; Yashiroda Y; Boone C; Dos Reis TF; Goldman GH
mBio; 2024 Jun; ():e0103124. PubMed ID: 38916308
[TBL] [Abstract][Full Text] [Related]
18. Blap-6, a Novel Antifungal Peptide from the Chinese Medicinal Beetle
Zhang LM; Zhou SW; Huang XS; Chen YF; Mwangi J; Fang YQ; Du T; Zhao M; Shi L; Lu QM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791374
[No Abstract] [Full Text] [Related]
19. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
Pereira TC; do Carmo PHF; de Menezes RT; de Oliveira HC; de Oliveira LD; Junqueira JC; Scorzoni L
Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
